What would you like to know about pregabalin patents? I can give a quick overview or look up country‑specific details if you specify the jurisdiction.
A general outline:
- Pregabalin (the active molecule) has been protected by multiple patent families worldwide, including the core composition-of-matter patent for pregabalin itself, plus patents on salts (e.g., pregabalin salts), crystalline forms, formulations, and methods of use (e.g., treatment of neuropathic pain, fibromyalgia, seizures).
- Patent expiry is country‑specific. In many major markets, the core molecule patent has expired or is expiring in the early to mid-2010s, which opened the door to generics. However, some use, salt/formulation, or method‑of‑use patents may have extended protection in certain jurisdictions into the late 2010s or early 2020s, and regulatory data exclusivities can also affect market entry.
- Because patent status can vary by country and can be affected by term extensions, reexamination, and legal challenges, it’s best to check the exact status for the country you care about (and the specific patent family: molecule, use, salt/formulation).
If you tell me:
- the country or region (e.g., United States, European Union, Japan, etc.), and
- whether you’re interested in the molecule patent, use patents, or formulation/salt patents,
I can give you a concise, country-specific summary and point you to the exact patent numbers and expiry dates (and where to look them up, like the USPTO Orange Book, Espacenet, or Patentscope).